0.01) after BS than after SS. Compliance of the respiratory system and V., were decreased after either BS or SS at 0.5 h ( p < 0.01) and remained decreased after S S at 2, h ( p < 0.01). There was no significant change in V, or VA after either BS or SS. Because FRC and a/A increased without an accompanying increase in V,, VA, or compliance of the respiratory system, we believe that the immediate increase in FRC in this study was caused by stabilization of gas exchange units already being ventilated in addition to recruitment of new units. Nitrogen clearance index decreased and effective breath fraction increased after treatment, indicating an improved efficiency in gas mixing also thought to result from stabilization and maintenance of patency of distal airways by surfactant. NCI, nitrogen clearance index EBF, effective breath fraction C, , compliance of the respiratory system R, , resistance of the respiratory-system BS, bovine surfactant (Survanta) SS, synthetic surfactant (Exosurf) a/A ratio, ratio of arterial to alveolar oxygen tension FIo2, fractional concentration of inspired oxygen Pao2, arterial oxygen tension Paco2, arterial carbon dioxide tension Even though surfactant treatment of premature infants with HMD has become a routine practice, many of the proposed physiologic mechanisms thought to govern the effect of surfactant on gas exchange remain either unconfirmed or inadequately characterized in the intact human newborn infant. Our understanding of physiologic responses to surfactant treatment in human infants is limited by difficulties involved in assessing pulmonary function, particularly measurements of lung volume and indices of gas mixing such as alveolar ventilation that require the accurate measurement of airway flow. To our knowledge, there are only three other reports (1-3) describing the effect of surfactant treatment on lung volume in human premature infants. Although there are more reports describing the effect of surfactant treatment on the mechanical properties of the lung in human infants (4-8), the results of those studies had to be interpreted without knowledge of change in lung volume. In this study, a whole-body plethysmograph (9) was used to measure airway flow, thereby avoiding problems associated with endotracheal tube pneumotachometry such as leak around the endotracheal tube and the added dead space of the pneumotachometer.
The purpose of this study was to describe how the effects of surfactant treatment on gas exchange are mediated by physiologic mechanisms in human premature infants with HMD. Gas exchange was expressed as the a/A ratio to reflect oxygenation and as Pacoz to reflect ventilation. The physiologic mechanisms responsible for changes in gas exchange after surfactant were investigated by measuring C,, R,, FRC, VT, VA, VA, and two indices of the efficiency of gas mixing. A second purpose of the study was to compare the effects of a BS, Suwanta, which contains surfactant-associated proteins B and C, with the effects of an SS, Exosurf, which contains no protein.
MATERIALS AND METHODS
FRC, V,, V,, v,, NC1, EBF, C,, R,, oxyhemoglobin saturation, Pao*, and PAcoz were measured before and serially after the administration of a sinde dose of either an SS. Exosurf. or a 496 COTTON and severity of lung disease in an effort to maintain comparability between the groups in regard to these factors. The investigators were not blinded in regard to type of surfactant. Measurements were obtained from all 17 patients at approximately 0.5 and 2 h after surfactant treatment. Measurements were also obtained 6 h after treatment from six of the patients who received BS and from eight of the patients who received SS. All the patients were receiving mechanical ventilation through an indwelling endotracheal tube. All were less than 24 h postnatal age when the study began.
Comparability between the group of patients treated with BS and the group treated with SS in regard to severity of pulmonary insufficiency was established using an index ( 10) expressed as the arithmetic product of venous admixture and mean applied proximal airway pressure calculated for each arterial blood gas determination between birth and time of study. The cumulative severity of pulmonary insufficiency between birth and time of study was derived by summing individual values of this arithmetic product, which had been time averaged to take into account uneven spacing between arterial blood gas samples. The overall comparability of the two surfactant groups in regard to this index and to other characteristics is given in Table 1 .
Before obtaining baseline measurements of lung function, study patients were given morphine sulfate and pancuronium bromide to suppress spontaneous respiratory effort. After muscle relaxation, ventilator settings were adjusted to achieve a pulse oximeter reading > 92% at an FIoz 5 0.8, and Pace? 5 5.5 kPa.
Bear Cub model BP 2001 respirators (Bear Medical Systems. Inc., Riverside, CA) were used to provide time-cycled, pressurelimited intermittent mandatory ventilation with positive endexpiratory pressure. After the ventilator settings had been adjusted to accommodate for suppression of spontaneous respiratory effort, they were maintained unchanged through the measurements made 2 h after treatment except for adjustments in FIo2 made to maintain pulse oximetry readings between 92 and 96%. Ventilator settings after the study at 2 h were left to the discretion of the medical staff managing the patient. Either SS. 5 mL/kg, or BS, 4 mL/kg, was given as a slow infusion (over 5-20 min) into the side port of an endotracheal tube adaptor (Respiratory Support Products, Inc., Irvine, CA) without disconnecting the patient from the ventilator circuit. The flow signal was compensated by the computer for the low-pass filtering influence of the plethysmograph. An airtight seal was established between the face and the cuffed face-out opening using a water-soluble gel (Aquasonic 100. Parker Laboratories Inc., Orange. NJ). Absence of leak in the svstem was verified bv com~aring the flow measured when a flow &oxygen was injected inti the aethysmograph and allowed to exit through the ~neumotachometer with the flow measured when the s a i e magAitude flow of oxygen was introduced directly through the pneumotachometer. Leak was considered insignificant when the difference between these two flow measurements was less than 5%. Leaks greater than 5% always could be eliminated by spreading additional gel around the margin between the cuff of the face-out port and the infant's face. If the leak were linear, a 5% leak would cause a 5% underestimate of expired Nz flow, which would cause FRC to be underestimated by 5%. VT was obtained by integration of the compensated plethysmograph flow signal over a single breath. FRC. VA. VA, and NCI were measured using a multiple-breath nitrogen washout technique ( I I). Expired Nz concentration at the endotracheal tube adapter was measured continuously using a model 505 Nitralyzer (Med Science. Needham Heights. MA) before and after switchover during expiration to a second mechanical ventilator that delivered an FIol of 1.0 at settings identical to the first ventilator. The N? concentration and flow signals were sampled at a frequency of 250 Hz and recorded by the computer until the washout was manually terminated when expired Nz concentration remained below 2.0%. The volume of Nl expired during the washout was measured by integrating the instantaneous product of flow and N2 concentration during each expiration and inspiration.
FRC in mL body temperature, pressure, saturation was calculated as the volume of Nz expired during the washout divided by the difference between the end-expiratory Nz concentration before switchover and final end-expiratory Nz concentration of the washout. This method has been extensively validated in a mechanical lung and in newborn infants (9. 12). Based on two to six replicate measurements of FRC on 27 occasions in six infants in the Vanderbilt newborn intensive care unit, the coefficient of variation and standard error of the estimate were found to be 6.6% and 0.8 mL. respectively. Measurements of FRC in four rabbits before and after bronchoalveolar lavage with saline documented a correlation of 0.93 between values obtained by this technique and by helium dilution over a range of 5-30 mL/ kg (unpublished data).
VA was derived from the Nz elimination curve, which was constructed by expressing the volume of Nz remaining in the lung after the nth breath of the washout, V N (~) , as an exponential function of the breath number, n: VN(n) = VN(0).wn. VN(O), the initial Nz volume in the lung, was calculated as VN(0) = FRC. FEN?, where FEN? was the concentration of Nz in expired gas before the washout. The washout dilution factor, w, was estimated by linear regression analysis after an appropriate linear transformation. V A was then calculated from w and FRC: VA = (( 1 -w)/wJ. FRC. VA was calculated as the product of VA and the rate of mechanical ventilation in breaths per min. Additional details and theoretical considerations of this technique are documented elsewhere ( 1 1 -13).
Efficiency of gas mixing was estimated by two indices, NCI and EBF (14) . NCI was calculated as the ventilatory volume necessary to dilute the nitrogen lung volume from 90 to 10% of its total value, divided by the FRC (n.VT/FRC). EBF was calculated as VA/VT. C, and R, were calculated from airway pressure measured at the proximal end of the endotracheal tube and airway flow was measured from the plethysmograph as described above. Ten-to 20-s segments of these signals sampled by the computer at a frequency of 250 Hz were recorded for later analysis. Pressure was measured using a pressure transducer (Validyne model MP45-28-97 1 ) connected to the switchover junction between the proximal end of the endotracheal tube and the two ventilator circuits. The lengths of the rigid tubes connecting the transducers to the proximal airway and to the pneumotachometer had been adjusted to maintain the proper phase relationship between the pressure and flow signals. C, and R, were derived from the linear equation P(t) = ( I/C,). $ V(t)dt + R,. V(t), where P(t) and
are proximal airway pressure and airway flow, respectively, at time t. V(t) was integrated over a single breath and C, and R, were estimated for each individual breath using linear regression analysis. Values of C, and R, reported here represent averages from five to 10 breaths. A detailed description of this technique and its validation have been previously published ( 12. 13).
The study was approved by the Vanderbilt Committee for the Protection of Human Subjects. Informed consent was obtained before each patient was studied.
Statistical methods. A t test was used to assess statistical significance between groups at specific time points. Difference from baseline within a group was assessed using a paired t test. Similar results were found when the equivalent nonparametric tests (Wilcoxon Rank Sum Test or Wilcoxon Signed Rank Test) were used. A repeated measures analysis of variance was used to assess whether changes over time were different between the two groups. These differences were detected by the time-treatment interaction term. Significance of the association between changes in variables measured over time after surfactant treatment was assessed using regression coefficients calculated from models with the regression forced through zero. Similar conclusions were obtained when regression was performed on observed values adjusted for patient-to-patient differences.
RESULTS
Results of pulmonary function measurements made before and after surfactant treatment are summarized in Table 2 grouped according to the type of surfactant administered. There were no significant differences in the baseline values of these measurements between the group treated with BS and the group treated with SS ( p > 0.1 for all measurements). The a/A ratio and FRC increased significantly after treatment with either BS or SS. These changes were first detected 0.5 h after BS treatment, but not until 2 h after SS treatment. The increases in FRC and a/A ratio at 0.5 and 2 h after treatment were significantly greater in the BS group than in the SS group. The increase in FRC remained significantly greater at 6 h in the BS group than the SS group, whereas the difference in a/A ratio increase between the two groups was no longer significant by this time. A significant decrease in C, was detected at 0.5 h after treatment with either BS or SS. A significant decrease in C, was still detectable 2 h after SS treatment. Significant decreases also were detected in VT after either BS or SS. The time pattern ofthese changes paralleled the changes in C,. There were significant decreases in R, 2 and 6 h after SS, but no significant change in R, was observed after BS at any time. No significant changes in Pacoz, VA, or VA were detected.
The results of measurements of gas mixing efficiency before and after surfactant treatment are shown in Table 3 . Because there were no differences in either the baseline values or the changes from baseline between the BS and SS groups ( p > 0.2 in all cases), the two groups were considered together. Both the decrease in NCI and the increase in EBF after treatment indicate an improvement in the efficiency of gas mixing.
There was a significant association between change in a/A ratio and change in FRC for both surfactants (Fig. I ) . The a/A ratio increased by 0.027 f 0.004 per mL/kg increase in FRC for the SS group ( p < 0.001) and by 0.023 f 0.003 per mL/kg for the BS group ( p < 0.001). There is no evidence that the change in a/A for a given change in FRC was different for the two surfactants ( p > 0.4). Pacoz decreased as VA increased for both surfactants (Fig. 2) . This decrease is more marked for the BS group (-0.0 18 +-0.005 kPa per ml. kg-'. min-' increase. p < 0.01) than for the SS group (-0.006 f 0.003. p < 0.05). and these two slopes are significantly different ( p < 0.05).
DISCUSSION
Infants in this study treated with either BS or SS responded with improved oxygenation accompanied by an increase in FRC. With either surfactant, there was a significant association between the change in a/A ratio and the change in FRC. These results, which are consistent with our preliminary findings ( I 5) and which are similar to those of Edberg (./ ul. ( I ) and Goldsmith et 01. (2) , document the importance of FRC changes in the mechanism of improved oxygenation after surfactant treatment of infants with HMD. Based on theoretical considerations and experimental animal studies, it is likely that the increase in FRC after surfactant treatment represents either the recruitment of new gas exchange units, the stabilization of units so that they do not collapse during expiration, or a combination of both actions.
For a given volume of FRC increase. the two surfactant preparations appear to be equivalent in regard to the magnitude of improvement in oxygenation, inasmuch as the slopes of a/A ratio change as a function of FRC change were almost identical for the two groups (Fig. I) . However, the time patterns of the improvement in oxygenation and of the increase in FRC were significantly different between the two surfactants, with both a/ A ratio and FRC increasing sooner and to larger values in infants receiving BS than in infants receiving SS. These differences in response between BS and SS may reflect differences in physicochemical properties between the two surfactant preparations. When used to treat newborn premature rabbit pups before air breathing, SS had a less intense beneficial effect on lung mechanical properties than natural surface-active material ( 16) . This difference was attributed to the absence of surfactant apoproteins in SS and to properties such as adsorption rate and spreading. which approach but do not equal those of purified natural lung surfactant containing trace components such as apoproteins. In the same study. no difference was observed in onset of action between SS and natural surface-active material as measured by rate of increase in VT during the first minute of ventilation. However, the human infants in the present study did not receive surfactant treatment until 4 to 23 h after birth. When surfactant is administered to premature lambs after mechanical ventilation, its distribution in the lungs is more heterogeneous than when it is administered at birth before the first breath (17. 18) . A delay in onset of action related to physicochemical properties would possibly be exaggerated if the surfactant preparation were heterogeneously distributed in the lungs. It is also possible that the distribution of either BS or SS was influenced by the technique of instillation used in this study or the duration of the infusion.
Other factors may also contribute to the intensity and time of onset of FRC and a/A ratio responses after surfactant treatment. The biophysical activity ofsurfactant may be inhibited by protein leaked into airways ( I 9.20). Two factors considered to be related to the amount of protein leaked into airways by the time of study, postnatal age at surfactant treatment and cumulative severity of pulmonary insufficiency, were not statistically different between the two groups. However. the large SD of these variables and the higher mean of each variable in the SS group make it difficult to exclude completely the possible effect of these factors in this study. Also, some synthetic surfactants (although not Exosurf) have been reported to be less resistant to the 498 COTTON ET .4L inhibitory effects of plasma proteins and their derivatives than surfactants containing surfactant-associated proteins (2 1 ). In addition, birth weight, gestational age, acidosis, Pao2 immediately before treatment (22) , and FIo2 at the time of treatment (23) have also been identified as risk factors for an attenuated response in oxygenation after surfactant treatment. However, the two groups of patients in this study were similar in regard to these factors. An improvement in oxygenation and an increase in FRC do not necessarily imply the recruitment of new gas exchange units. The stabilization of gas exchange units (24) that were already being ventilated before surfactant treatment would also be expected to lead to an increase in FRC and Paoz. During deflation, unstable alveoli collapse at their critical closing pressures. If capillary perfusion of these alveoli continues while they are collapsed, the resulting venous admixture will contribute to the overall intrapulmonary shunt and arterial hypoxemia. When unstable alveoli have been stabilized by surfactant repletion, they deflate progressively without collapse so that they retain gas volume at end-expiratory pressures below their previous critical closing pressures (24, 25) . In stabilized alveoli, effective gas exchange with pulmonary capillary blood can take place during expiration as well as during inspiration.
The stabilization of gas exchange units already being ventilated before surfactant treatment could be one explanation for the decrease in C, observed in these patients. In HMD, there is a large compartment of unventilated or poorly ventilated alveoli (26, 27). To attain a normal alveolar ventilation, the remaining ventilated alveoli must provide more than their normal share of C 0 2 transport. The smaller the ventilated compartment, the more distended will its alveoli become at end inspiration for a given tidal volume. At high volume, tissue elastance of alveolar units increases so that transpulmonary pressures in alveoli that have been distended to near maximal volume at end inspiration would be nearly the same in the presence or absence of surfactant (24, 28) . Although surfactant treatment might have only little effect on the volume ofthese distended alveoli at end inspiration, their end-expiratory volumes would be increased by the stabilizing effect of surfactant. As a result, the volume change in these alveoli during a ventilatory cycle would decrease after surfactant treatment if ventilating pressures remained constant and if other factors such as airway resistance did not change. Consequently, C, would also decrease. This decrease in dynamic C, accompanying alveolar stabilization after surfactant treatment does not imply that surfactant treatment has failed to decrease lung recoil forces. To the contrary, stabilization has occurred because the recoil force at airliquid interfaces in ventilated alveoli has been lowered by surfactant, allowing volume to be retained at an end-expiratory pressure that before surfactant treatment was insufficient to overcome the higher recoil force. C,, either dynamic or static. when measured over a fixed range of positive airway pressure before and after surfactant treatment, would be obtained from a pressure-volume curve that had become "flattened" after surfactant because of an elevation in volume at end expiration.
If the initial effect of surfactant treatment is limited to only those alveoli that are ventilated (either unstable or stabilized in the presence of positive end-expiratory pressure), lung compliance can only decrease when measured under the conditions described above. If the effect of surfactant treatment also includes recruitment of new terminal air spaces, lung compliance may increase, remain unchanged, or decrease, depending in part on how many alveoli have been recruited. For this reason, the results obtained in this study cannot be used to distinguish between stabilization and recruitment as mechanisms leading to the observed increase in FRC. Although not obtained in our study. static pressure-volume curves as measured in premature lambs by Vilstrup et a/. (29) and in premature human infants with respiratory distress syndrome by Bjorklund et ul. (30) would help distinguish between stabilization and simple volume recruitment.
The lack of any significant changes in V,, V,, or Paco2 after treatment even though VT decreased implies a surfactant-induced improvement in gas mixing efficiency. The changes observed in the two indices of gas mixing efficiency measured in this study, EBF and NCI, also indicate improved gas mixing and are consistent with similar findings in premature lambs by Sandberg et 01. (14) and by Vilstrup et a/. (29) , which were attributed to a stabilization of distal airways by surfactant and maintenance of patency of the peripheral airways and alveoli.
In other ways, the results in this study differ from those obtained by Sandberg c2t a/. (14) and Vilstrup rt a/. (29) when premature lambs were treated with natural surfactant at or shortly after birth. Sandberg er a/. (14) observed that treated lambs not only had a higher a/A ratio and FRC compared with There is a significant difference between untreated control lambs of similar gestational ages, but they also had a higher dynamic C,, higher V,, and lower Paco. than the control group. The higher dynamic C, and higher V, were observed at the time of the initial measurements after surfactant treatment when both the treatment group and control group were being ventilated with similar high airway pressures. In a related study, Vilstrup et a/. (29) also observed that the increase in a/A ratio and FRC in newborn premature lambs after surfactant treatment at 25 min after birth was accompanied by an increase in both dynamic and maximum C, along with an increase in VT and a decrease in Pacoz. Ventilation and dynamic C, improved in their animals even though ventilator pressures were not reduced after surfactant treatment. In contrast. V, did not change significantly and C, decreased in our infants after treatment. The difference in the effect of surfactant treatment on dynamic C, and ventilation between these two studies of lambs and our study of human infants may have reflected the time of surfactant administration, i.e. whether surfactant was given "prophylactically" at or shortly after birth or as a "rescue" treatment for established HMD. The effect observed in lambs given surfactant in the "prophylactic" mode is consistent with the recruitment of a larger number of open alveolar units than were attained in the control lambs. The effect observed in this study, when human infants were given surfactant in the rescue mode, is consistent with an increase in FRC caused by stabilization of units already being ventilated as well as by recruitment of new units.
The immediate increase in FRC after surfactant treatment probably involves both the stabilization of gas exchange units already being ventilated and the recruitment of new units. The relative contribution of each of these two mechanisms may depend on a large number of factors such as whether surfactant is given before or after the first breath, the degree to which terminal conducting airways are obstructed by cell slough and other products of epithelial injury (i.e. the hyaline membrane), the magnitude of end-expiratory and peak inspiratory pressures, the use of volume recruiting maneuvers such as application of sustained inflations (3 1) during or before surfactant administration, the effectiveness of spontaneous respiratory efforts, and the presence of other conditions that might promote or discourage alveolar recruitment. In many ways, the conditions of this study discouraged recruitment. Surfactant was given 4 to 23 h after birth. The patients had been given pancuronium and morphine to suppress spontaneous respiratory efforts. They were not turned and sighed as part of the surfactant administration routine. As a consequence, although some recruitment of new alveoli probably did occur, we hypothesize that the stabilization of alveoli already being ventilated contributed substantially to the FRC response observed immediately after surfactant administration with the result that C, decreased and no increase in V, was detected. Other studies (1, 2, 4-8) of human infants with HMD have also shown C, to decrease or remain unchanged immediately after surfactant treatment. These studies were similar to ours in that surfactant was given after the diagnosis of HMD had been established rather than prophylactically, and except for one study (7), measurements of dynamic C, were made from pressure and flow signals recorded during breaths provided by mechanical ventilation. When measurements were repeated from 12 to 72 h after surfactant administration, C, was observed to increase, probably as a result of ongoing alveolar recruitment and clearing of excess lung water. In some studies, an immediate increase in C, was measured in human infants immediately after surfactant treatment, but only when spontaneous breaths were analyzed (4), when static C, was measured by a passive flow-volume technique (32) , or when maximum C, was obtained from recording volume and pressure change during passive, interrupted exhalation to zero pressure (30) .
Interpretation of changes in lung compliance, especially dynamic C,, after surfactant treatment must be made with caution. A wide variety of factors may influence C, as measured in this and other studies. The age of the infant and prior course of ventilation, volume history of the lung, status of lung water content and distribution, pressures and rate of mechanical ventilation, the infant's spontaneous ventilatory effort, and forces resulting from the interdependence between alveolar structures are but a few of the factors that should be kept in mind when interpreting measurements of lung compliance. In addition, the ~hvsicochemical characteristics of the instilled surfactant in reb i d to adsorption rate and spreading, viscosity, and other properties are also important considerations. In this study, a decrease in C, was detected after SS before any significant change in FRC. It is possible that the decrease in C, in these patients was a consequence of the bulk presence of the exogenous liquid surfactant preparation instilled into the airways. Constriction of distal airways is known to cause a decrease in dynamic C, (33) . An accumulation of inadequately spread liquid surfactant in the distal airways could have a similar effect on C, with either surfactant preparation. Lack of any significant change in R, after BS and the observed decrease in R, after SS do not support this explanation. However, it should be kept in mind that other factors affecting R, could obscure any change in R, that might result from the bulk presence of exogenous liquid surfactant in the airways.
Although there were no significant treatment effects of BS or SS on V, or Pacoz, the expected association observed between Paco2 and VA in patients receiving BS was only weakly present in the SS group (Fig. 2) . The implication of this finding is that changes in anatomical dead space occurring in patients treated with SS were associated with only minimal changes in physiologic dead space. The reasons for this difference between BS and SS are unclear.
Studies at 6 h were not obtained in two patients receiving SS and one patient receiving BS. Failure to obtain these studies was related to conflicting commitments on the part of the research personnel. The 6-h data were not essential to our final conclusions, but having these data points for 14 of the 17 study patients provided added confidence in these conclusions. Three additional patients were enrolled in this study, but their results were excluded from analysis-one because the lung disease was complicated by sepsis, another because the lung disease was complicated by progressive shock and disseminated intravascular coagulation, and the third because the age at the beginning of study was greater than 24 h.
Our measurements of FRC, VA, v,, and NCI were dependent on a multiple-breath Nz washout technique adapted for critically ill premature infants. A major source of error, leak around the endotracheal tube, was eliminated by using whole-body plethysmography to measure airway flow. The technique has been extensively validated by its developers (1 1 -13 ). Its precision in our hands has been found to be highly acceptable.
Within 6 h after rescue administration, the short-term effect of surfactant treatment on gas exchange in this study of premature infants with established HMD was improved oxygenation without any significant change in ventilation. This effect was accompanied by an increase in FRC, a decrease in C, and VT. and little or no change in V, and V,. These results are consistent with a hypothesis that the increase in FRC immediately after rescue treatment with surfactant is caused by stabilization of gas exchange units already being ventilated as well as by recruitment of new units. NCI decreased and EBF increased after treatment, indicating an improved efficiency in gas mixing also thought to result from stabilization and maintenance of patency of distal airways by surfactant. Oxygenation and FRC improved sooner and to a greater extent after BS compared with SS. These differences in response may reflect differences in physicochemical properties such as adsorption rate and spreading between the two surfactant preparations.
